Medical authorities in Europe recently approved the use of a drug to treat Coronavirus on the continent.
The European Commission approved the drug Remdesivir, which prevents the virus from replicating within the body.
This is the first drug that is specially indicated to treat severe cases of Covid-19 in Europe.
At the moment, the medicine is only indicated for adolescents from 12 years of age and adults with severe pneumonia.
A final medical meeting of the European Commission is still needed to fully approve its use, this will be held next week.
Preliminary results of a study in the New England Journal of Medicine (NEJM) detail that the drug reduces the lethality of the virus by 7% to 12% in severe patients helping to speed up recovery.
The European Medicines Agency shares criteria on the use of Remdesivir with other medical studies and organisations, which would help in the rapid approval of Remdesivir.
Remdesivir comes from uses against Ebola and influenza and is produced in the laboratories of the company Gilead Sciences of the state of California in the USA.